Shares of genedrive plc (LON:GDR – Get Free Report) fell 6.1% during trading on Monday . The stock traded as low as GBX 0.95 and last traded at GBX 0.98. 17,727,824 shares changed hands during trading, a decline of 13% from the average session volume of 20,385,285 shares. The stock had previously closed at GBX 1.04.
genedrive Price Performance
The stock has a market capitalization of £10.04 million, a PE ratio of -0.45 and a beta of -0.04. The firm’s 50 day simple moving average is GBX 0.49 and its 200 day simple moving average is GBX 1.04. The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
See Also
- Five stocks we like better than genedrive
- Breakout Stocks: What They Are and How to Identify Them
- Is Lemonade Stock Set for a Big Squeeze After Earnings?
- With Risk Tolerance, One Size Does Not Fit All
- Caterpillar Stock Could Top $650 by Year’s End
- How to Start Investing in Real Estate
- ServiceNow’s 5-for-1 Split Is a Signal for Investors to Buy
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
